Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2008

View Archived Issues

Amgen presents results from a phase II study of AMG-108 in RA patients

Trial data show beneficial effects of epratuzumab in systemic lupus erythematosus

Atrasentan-liposomal doxorubicin combination feasible in platinum-resistant ovarian cancer

Nanocort safe in rheumatoid arthritis patients

ITF-2357 affects disease activity in systemic onset juvenile idiopathic arthritis

Esreboxetine improves pain, function and fatigue in double-blind fibromyalgia study

Athersys achieves development milestone in Bristol-Myers discovery alliance

Duska and DSM enter manufacturing collaboration for ATPace

Medtronic acquires CryoCath Technologies

Clinical data on CP-690550 in rheumatoid arthritis accumulates

AMG-623 characterized in phase I studies in systemic lupus erythematosus patients

FDA accepts TheraQuest's IND for abuse deterrent opioid TQ-1015

Novel compounds for lipoprotein disorders described in recent patents

Genetic Immunity doses first patient in phase II DermaVir Patch trial for HIV

Sygnis receives European orphan drug status for AX-200 in spinal cord injury

New antidiabetic agents disclosed in recent patent literature

GSK and Janssen patents divulge new therapeutics for GI disorders

Recent patent literature reports new oncolytic agents

Daiichi Sankyo commences phase III anti-influenza CS-8958 trial

FDA approves Banzel as adjunctive treatment for Lennox-Gastaut syndrome

Vernalis presents an update on clinical activities between July and November 2008

Third quarter highlights at AEterna Zentaris

Pfizer launches independent research unit Pfizer Regenerative Medicine

New glycine transporter GlyT1 inhibitor profiled at Merck & Co.

Merck Eprova imparts new PET imaging agents in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...